Discover 1,655 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,655
Active & Responsive
Opioids, Low Nicotine Cigarettes, and Chronic Pain
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 12 - 70+
Code: NCT06594913
Recruiting
Active & Responsive
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
for
Hereditary Hemorrhagic Telangiectasia (HHT),
Location: Chapel Hill NC, Augusta GA, Indianapolis IN, Boston MA,
Sponsor: Atavistik Bio, Inc
Sex: All
Age: 18+
Code: NCT07601425
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
for
Charcot Marie Tooth Disease
Location: Chapel Hill NC, Baltimore MD, Philadelphia PA,
Sponsor: Michael Shy
Sex: All
Age: 0+
Code: NCT01193075
Recruiting
Active & Responsive
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Chapel Hill NC, Savannah GA, Norcross GA,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07489651
Phase 2, Recruiting
Active & Responsive
Sugary Drink Labeling Study
for
Health Behavior
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18+
Code: NCT07294053
Recruiting
Active & Responsive
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for
Autosomal Dominant Polycystic Kidney Disease
Location: Chapel Hill NC, Winston-Salem NC, Knoxville TN,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18 - 55
Code: NCT06902558
Phase 2, Recruiting
Active & Responsive
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention